Company Profile

The DNA Medicine Institute (AKA: Chan Research, Inc~DNA Medicine Institute)
Profile last edited on: 4/1/2023      CAGE: 34SL6      UEI: PUESWMALMKD4

Business Identifier: Med-tech incubator, laboratory, and biomedical technology service provider
Year Founded
2004
First Award
2005
Latest Award
2024
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

727 Massachusetts Avenue
Cambridge, MA 02139
   (617) 913-7630
   info@dnamedinstitute.com
   www.dnamedinstitute.com
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

Taking a quite different approach to that of other firms in similar space, DNA Medicine Institute, Inc (DMI) is a medical device company addressing the seamless merging of science and engineering - leveraging an in-depth background in interdisciplinary science to achieve innovative commercial solutions. Describing themselves as a med-tech incubator, laboratory, and biomedical technology service provider, the firm is primarily focused on advancing the rHEALTH diagnostic technology, designed to provide multiple lab values off a single drop of blood. The firm's the rHEALTH technology is being developed for NASA’s upcoming mission to Mars effectively to provide comprehensive biomedical analysis for crew members. The firm's developed pPoducts are marketed through partner organizations, either spin-outs from DMI or partner market-facing companies. DNA's e rHEALTH won the XPRIZE’s Nokia Sensing XChallenge and was a Finalist in the Qualcomm Tricorder XPRIZE.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
20-24

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1742212387 2 NIH $1,022,909
Project Title: 5-Minute Point-of-Care Anti-Factor Xa Test for Emergent Patient Management
2024 2 NIH $2,473,815
Project Title: FVIII Point-Of-Care Monitoring Device and App
2018 2 NIH $4,072,576
Project Title: Stat Palm-Sized Blood Counter
2015 2 NASA $1,023,425
Project Title: rHEALTH X with Non-Invasive Capabilities for Science and Crew Health
2010 2 NASA $699,998
Project Title: Nanoscale Test Strips for Multiplexed Blood Analysis

Key People / Management

  Eugene Yan-Ho Chan -- Founder, President, and Chief Scientific Officer

  Chris Aiston -- Product Engineer and Industrial Design.

  Marcus Atkin -- Industrial Designer.

  Candice Bae -- Scientist I.

  Bill Bauer -- EE/CS

  Samuel Bearg -- Special Projects Scientist.

  Andy Bell -- Assay Specialist

  Dexter Eames -- Electrical Engineer

  Chung Han -- Instrumentation Specialist.

  Madeline Lee -- Assay Specialist

  Lillian Li -- Business Development Associate.

  Kevin McKenna -- Software Engineer

  William Phipps -- R&D Specialist.

  Julia Z Sharpe